Stryker (NYSE:SYK) this week announced it opened a new research and development facility in India.
Dubbed Stryker’s Global Technology Center (SGTC), the 150,000 sq. ft facility will be based at the International Tech Park in Gurgaon and will help accelerate innovation in India.
“Innovation is in Stryker’s DNA. SGTC strengthens our ability to innovate and develop new products and solutions that help improve and save lives around the world. We are proud that Stryker positively impacts more than 100 million patients’ lives each year and the demand for our offerings is growing,” Stryker’s MedSurg and Neurotechnology Group President Andy Pierce said in a news release.
Stryker established its first research and development facility in India more than 15 years ago with the purpose to support R&D functions in domestic and other emerging markets. With more than 1,000 employees at its first facility, the new SGTC furthers Stryker’s commitment to India.
“Together with our customers, we are driven to make healthcare better. We work to develop products and solutions that serve the unique needs of the market and our customers across the globe. We are excited about the strength of our current team and the diverse talents our new center will attract, which will drive innovation that benefits our customers and patients, not only in the region, but worldwide. The new center gives us room to grow and impact more people,” said Ram Rangarajan, VP of R&D at Stryker’s SGTC.
